By Ben Hirschler LONDON (Reuters) - British drugmaker AstraZeneca (LSE:AZN) warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expires on key medicines. ...
via Business News http://finance.yahoo.com/news/astrazeneca-warns-higher-costs-drug-084417364.html
via Business News http://finance.yahoo.com/news/astrazeneca-warns-higher-costs-drug-084417364.html
0 commentaires:
Enregistrer un commentaire